These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6721447)

  • 1. Effect of high-dose intravenous steroid administration on contrast-enhancing computed tomographic scan lesions in multiple sclerosis.
    Troiano R; Hafstein M; Ruderman M; Dowling P; Cook S
    Ann Neurol; 1984 Mar; 15(3):257-63. PubMed ID: 6721447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group.
    Beck RW; Cleary PA; Trobe JD; Kaufman DI; Kupersmith MJ; Paty DW; Brown CH
    N Engl J Med; 1993 Dec; 329(24):1764-9. PubMed ID: 8232485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of oral corticosteroid dosage on CT enhancing multiple sclerosis plaques.
    Troiano RA; Hafstein MP; Zito G; Ruderman MI; Dowling PC; Cook SD
    J Neurol Sci; 1985 Aug; 70(1):67-72. PubMed ID: 4045501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A short-term randomized MRI study of high-dose oral vs intravenous methylprednisolone in MS.
    Martinelli V; Rocca MA; Annovazzi P; Pulizzi A; Rodegher M; Martinelli Boneschi F; Scotti R; Falini A; Sormani MP; Comi G; Filippi M
    Neurology; 2009 Dec; 73(22):1842-8. PubMed ID: 19949030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Steroid therapy for multiple sclerosis].
    Oishi C; Sakuta M
    Nihon Rinsho; 2003 Aug; 61(8):1361-6. PubMed ID: 12962024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose glucocorticoids in multiple sclerosis patients exert direct effects on the kidney and skeleton.
    Cosman F; Nieves J; Herbert J; Shen V; Lindsay R
    J Bone Miner Res; 1994 Jul; 9(7):1097-105. PubMed ID: 7942157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.
    Ramo-Tello C; Grau-López L; Tintoré M; Rovira A; Ramió i Torrenta L; Brieva L; Cano A; Carmona O; Saiz A; Torres F; Giner P; Nos C; Massuet A; Montalbán X; Martínez-Cáceres E; Costa J
    Mult Scler; 2014 May; 20(6):717-25. PubMed ID: 24144876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New perspectives in computed tomography of multiple sclerosis.
    Viñuela FV; Fox AJ; Debrun GM; Feasby TE; Ebers GC
    AJR Am J Roentgenol; 1982 Jul; 139(1):123-7. PubMed ID: 6979846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of pulse therapy on delayed contrast-enhancing CT scan lesion in a patient with multiple sclerosis].
    Konishi T; Saida T; Nishitani H
    Rinsho Shinkeigaku; 1986 Jan; 26(1):71-5. PubMed ID: 3698407
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prospective assessment of combined treatment with high doses of intravenous methylprednisolone and long term administration of Isoprinosine in multiple sclerosis patients].
    Maciejek Z; Niezgodzińska-Maciejek A
    Neurol Neurochir Pol; 1993; 27(3):321-9. PubMed ID: 7694166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of methylprednisolone treatment on cerebral reactivity in patients with multiple sclerosis.
    Ozkan S; Uzuner N; Kutlu C; Ozbabalik D; Ozdemir G
    J Clin Neurosci; 2006 Feb; 13(2):214-7. PubMed ID: 16503485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CT of multiple sclerosis: reassessment of delayed scanning with high doses of contrast material.
    Spiegel SM; Viñuela F; Fox AJ; Pelz DM
    AJR Am J Roentgenol; 1985 Sep; 145(3):497-500. PubMed ID: 3875253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Similar biological effect of high-dose oral versus intravenous methylprednisolone in multiple sclerosis relapses.
    Grau-López L; Teniente-Serra A; Tintoré M; Rovira A; Ramió-Torrenta L; Brieva L; Saiz A; Cano A; Carmona O; Hervás JV; Martínez-Cáceres EM; Ramo-Tello C
    Mult Scler; 2015 Apr; 21(5):646-50. PubMed ID: 25145693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term steroid therapy in multiple sclerosis].
    Domzał T; Zalewska B
    Neurol Neurochir Pol; 1992; 26(5):621-5. PubMed ID: 1291899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations.
    Durelli L; Cocito D; Riccio A; Barile C; Bergamasco B; Baggio GF; Perla F; Delsedime M; Gusmaroli G; Bergamini L
    Neurology; 1986 Feb; 36(2):238-43. PubMed ID: 3511404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of various cardiac arrhythmias and conduction disturbances due to high dose intravenous methylprednisolone in patients with multiple sclerosis.
    Vasheghani-Farahani A; Sahraian MA; Darabi L; Aghsaie A; Minagar A
    J Neurol Sci; 2011 Oct; 309(1-2):75-8. PubMed ID: 21831398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Glucocorticoid treatment of acute optic neuritis and multiple sclerosis risk].
    Dtsch Med Wochenschr; 1994 Jun; 119(24):897. PubMed ID: 8005072
    [No Abstract]   [Full Text] [Related]  

  • 18. Intravenous methylprednisolone for multiple sclerosis in relapse.
    Barnes MP; Bateman DE; Cleland PG; Dick DJ; Walls TJ; Newman PK; Saunders M; Tilley PJ
    J Neurol Neurosurg Psychiatry; 1985 Feb; 48(2):157-9. PubMed ID: 2984332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The bioavailability of IV methylprednisolone and oral prednisone in multiple sclerosis.
    Morrow SA; Stoian CA; Dmitrovic J; Chan SC; Metz LM
    Neurology; 2004 Sep; 63(6):1079-80. PubMed ID: 15452302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [High dose methylprednisolone therapy in patients with multiple sclerosis].
    Zakrzewska-Pniewska BZ
    Neurol Neurochir Pol; 1993; 27(3):313-9. PubMed ID: 8232731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.